Abstract
Mental retardation (MR) is displayed by 57% of NF1 patients with microdeletion syndrome as a result of 17q11.2 region haploinsufficiency. We considered the cyclin-dependent kinase 5 regulatory subunit 1 (CDK5R1) and oligodendrocyte-myelin glycoprotein (OMG) genes, mapping in the NF1 microdeleted region, as candidate genes for MR susceptibility. CDK5R1 encodes for a neurone-specific activator of cyclin-dependent kinase 5 (CDK5) involved in neuronal migration during central nervous system development. OMG encodes for an inhibitor of neurite outgrowth by the binding to the Nogo-66 receptor (RTN4R). CDK5R1 and OMG genes are characterized by large 3′ and 5′ untranslated regions (UTRs), where we predict the presence of several transcription/translation regulatory elements. We screened 100 unrelated Italian patients affected by unspecific MR for mutations in CDK5R1 and OMG coding regions and in their 3′ or 5′ UTRs. Four novel mutations and two novel polymorphisms for CDK5R1 and three novel mutations for OMG were detected, including two missense changes (c.323C>T; A108V in CDK5R1 and c.1222A>G; T408A in OMG), one synonymous codon variant (c.532C>T; L178L in CDK5R1), four variants in CDK5R1 3′UTR and two changes in OMG 5′UTR. All the mutations were absent in 370 chromosomes from normal subjects. The allelic frequencies of the two novel polymorphisms in CDK5R1 3′UTR were established in both 185 normal and 100 mentally retarded subjects. Prediction of mRNA and protein secondary structures revealed that two changes lead to putative structural alterations in the mutated c.2254C>G CDK5R1 3′UTR and in OMG T408A gene product.
Similar content being viewed by others
References
Molinari F, Rio M, Meskenaite V, Encha-Razavi F, Auge J, Bacq D, Briault S, Vekemans M, Munnich A, Attie-Bitach T, Sonderegger P, Colleaux L (2002) Truncating neurotrypsin mutation in autosomal recessive nonsyndromic mental retardation. Science 298:1779–1781
Higgins JJ, Pucilowska J, Lombardi RQ, Rooney JP (2004) A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation. Neurology 63:1927–1931
Venturin M, Guarnieri P, Natacci F, Stabile M, Tenconi R, Clementi M, Hernandez C, Thompson P, Upadhyaya M, Larizza L, Riva P (2004) Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2. J Med Genet 41:35–41
Gupta A, Tsai LH (2003) Cyclin-dependent kinase 5 and neuronal migration in the neocortex. Neurosignals 12:173–179
Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH (1997) Mice lacking p35, a neuronal specific activator of Cdk5, displays cortical lamination defects, seizures, and adult lethality. Neuron 18:29–42
Kwon YT, Tsai LH (1998) A novel disruption of cortical development in p35(–/–) mice distinct from reeler. J Comp Neurol 395:510–522
Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, Tsai LH (2001) p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 21:6758–6771
Namgung U, Choi BH, Park S, Lee JU, Seo HS, Suh BC, Kim KT (2004) Activation of cyclin-dependent kinase 5 is involved in axonal regeneration. Mol Cell Neurosci 25:422–432
Li BS, Zhang L, Takahashi S, Ma W, Jaffe H, Kulkarni AB, Pant HC (2002) Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J 21:324–333
Fischer A, Sananbenesi F, Schrick C, Spiess J, Radulovic J (2002) Cyclin-dependent kinase 5 is required for associative learning. J Neurosci 22:700–707
Cheng K, Ip NY (2003) Cdk5: a new player at synapses. Neurosignals 4–5:180–190
Paglini G, Peris L, Diez-Guerra J, Quiroga S, Caceres A (2001) The Cdk5–p35 kinase associates with the Golgi apparatus and regulates membrane traffic. EMBO Rep 2:1139–1144
Lau LF, Ahlijanian MK (2003) Role of cdk5 in the pathogenesis of Alzheimer’s disease. Neurosignals 12:209–214
Smith PD, Crocker SJ, Jackson-Lewis V, Jordan-Sciutto KL, Hayley S, MountMP, O’Hare MJ, Callaghan S, Slack RS, Przedborski S, Anisman H, Park DS (2003) Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson’s disease. Proc Natl Acad Sci U S A 100:13650–13655
Nguyen MD, Julien JP (2003) Cyclin-dependent kinase 5 in amyotrophic lateral sclerosis. Neurosignals 12:215–220
Ruggiero T, Olivero M, Follenzi A, Naldini L, Calogero R, Di Renzo MF (2003) Deletion in a (T)8 microsatellite abrogates expression regulation by 3′-UTR. Nucleic Acids Res 31:6561–6569
van der Velden AW, Thomas AA (1999) The role of the 5′ untranslated region of an mRNA in translation regulation during development. Int J Biochem Cell Biol 31:87–106
Jansen RP (2001) mRNA localization: message on the move. Nat Rev Mol Cell Biol 2:247–256
Bashirullah A, Cooperstock RL, Lipshitz HD (2001) Spatial and temporal control of RNA stability. Proc Natl Acad Sci U S A 98:7025–7028
Conne B, Stutz A, Vassalli JD (2000) The 3′ untranslated region of messenger RNA: a molecular ‘hotspot’ for pathology? Nat Med 6:637–641
Mazumder B, Seshadri V, Fox PL (2003) Translational control by the 3′-UTR: the ends specify the means. Trends Biochem Sci 28:91–98
Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, He Z (2002) Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417:941–944
Sinibaldi L, De Luca A, Bellacchio E, Conti E, Pasini A, Paloscia C, Spalletta G, Caltagirone C, Pizzuti A, Dallapiccola B (2004) Mutations of the Nogo-66 receptor (RTN4R) gene in schizophrenia. Hum Mutat 24:534–535
Vourc’h P, Dessay S, Mbarek O, Marouillat Vedrine S, Muh JP, Andres C (2003) The oligodendrocyte-myelin glycoprotein gene is highly expressed during the late stages of myelination in the rat central nervous system. Brain Res Dev Brain Res 144:159–168
Morris DR, Geballe AP (2000) Upstream open reading frames as regulators of mRNA translation. Mol Cell Biol 20:8635–8642
Luckasson R, Coulter DL, Polloway EA, Reiss S, Schalock RL, Snell ME, Spitalnik DM, Stark JA (1992) Mental retardation: definition, classification and systems of supports, 9th edn. American Association on Mental Retardation, Washington, DC
American Psychiatric Association (2000) Diagnostic and Statistical Manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
Williams CA, Lossie A, Driscoll D (2001) Angelman syndrome: mimicking conditions and phenotypes. Am J Med Genet 101:59–64
Tompa P, Buzder-Lantos P, Tantos A, Farkas A, Szilagyi A, Banoczi Z, Hudecz F, Friedrich P (2004) On the sequential determinants of calpain cleavage. J Biol Chem 279:20775–20785
Kam R, Chen J, Blumcke I, Normann S, Fassunke J, Elger CE, Schramm J, Wiestler OD, Becker AJ (2004) The reelin pathway components disabled-1 and p35 in gangliogliomas—a mutation and expression analysis. Neuropathol Appl Neurobiol 30:225–232
Bevilacqua A, Ceriani MC, Capaccioli S, Nicolin A (2003) Post-transcriptional regulation of gene expression by degradation of messengerRNAs. J Cell Physiol 195:356–372
Lai EC, Posanoky JW (1997) The Bearded box, a novel 3′ UTR sequence motif, mediates negative post-transcriptional regulation of Bearded and Enhancer of split Complex gene expression. Development 124:4847–4856
Stark A, Brennecke J, Russell RB, Cohen SM (2003) Identification of Drosophila MicroRNA targets. PLoS Biol 1:E60
Lai EC, Tam B, Rubin GM (2005) Pervasive regulation of Drosophila Notch target genes by GY-box-, Brd-box-, and K-box-class microRNAs. Genes Dev 19:1067–1080
Vourc’h P, Moreau T, Arbion F, Marouillat-Vedrine S, Muh JP, Andres C (2003a) Oligodendrocyte myelin glycoprotein growth inhibition function requires its conserved leucine-rich repeat domain, not its glycosylphosphatidyl-inositolanchor. J Neurochem 85:889–897
Vourc’h P, Martin I, Marouillat S, Adrien JL, Barthelemy C, Moraine C, Muh JP, Andres C (2003b) Molecular analysis of the oligodendrocyte myelin glycoprotein gene in autistic disorder. Neurosci Lett 338:115–118
Kesavapany S, Li BS, Amin N, Zheng YL, Grant P, Pant HC (2004) Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide. Biochim Biophys Acta 1697:143–153
Acknowledgements
The authors thank Professor Graziano Pesole (Department of Biomolecular Sciences and Biotechnology, University of Milan) for his helpful suggestions on UTR regulatory elements searching, Elena Gismano and Rosina Paterra fo their technical support. This work was supported by FIRST to PR.
Author information
Authors and Affiliations
Corresponding author
Additional information
M. Venturin and S. Moncini equally contributed to this work.
Rights and permissions
About this article
Cite this article
Venturin, M., Moncini, S., Villa, V. et al. Mutations and novel polymorphisms in coding regions and UTRs of CDK5R1 and OMG genes in patients with non-syndromic mental retardation. Neurogenetics 7, 59–66 (2006). https://doi.org/10.1007/s10048-005-0026-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10048-005-0026-9